Evidence map›Paper›PMID 37444666›Full record

ArticleHealthcare (Basel, Switzerland)2023

Management and Prevention of Pre-Eclampsia in Nigeria.

Oluwabunmi Victoria Adeyeye, Nwikwu Vivian Ebubechukwu, Omotayo Faith Olanrewaju, Aderayo Grace Eniayewun, Chidinma Nwuta, Fortune Benjamin Effiong, Brigid Unim

Open access · goldAbstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Oluwabunmi Victoria AdeyeyeDirectorate of Research, TORASIF, Calabar 540004, Nigeria.
Nwikwu Vivian EbubechukwuDirectorate of Research, TORASIF, Calabar 540004, Nigeria.
Omotayo Faith OlanrewajuDirectorate of Research, TORASIF, Calabar 540004, Nigeria.ORCID 0000-0003-1286-8272
Aderayo Grace EniayewunDirectorate of Research, TORASIF, Calabar 540004, Nigeria.
Chidinma NwutaDirectorate of Research, TORASIF, Calabar 540004, Nigeria.
Fortune Benjamin EffiongDirectorate of Research, TORASIF, Calabar 540004, Nigeria.
Brigid UnimDepartment of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Via Giano della Bella 34, 00162 Rome, Italy.ORCID 0000-0002-6522-9098
University of Ibadan · NGUniversity of Nigeria · NGIstituto Superiore di Sanità · ITUniversity of Calabar · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This research paper analyses the management and prevention of pre-eclampsia in Nigeria. Although efforts have been made to reduce outcomes due to pre-eclampsia, it still rears its head in the form of high maternal and perinatal morbidity and mortality. The aim of this review was to identify the main obstacles, gaps, and interventions related to the prevention and management of pre-eclampsia in order to be fully knowledgeable of the magnitude of the issue at the national level, to assess if current government policies are adequate and to recommend solutions. A search was performed on online databases and it was completed with hand searches related to the subject matter. Screening tests for early detection of pre-eclampsia are hardly available in Nigeria as many hospitals rely on the history of previous and current pregnancies, blood pressure monitoring and urinalysis-proteinuria. The administration of low-dose aspirin, antihypertensive drugs and magnesium sulphate, coupled with calcium in calcium deficit regions, was recommended. The main barriers to the wider implementation of these strategies are inadequacy of the antenatal care services in providing appropriate care, lack of resources and trained personnel, high healthcare costs, and low antennal care attendance. Improving education and awareness, use of low-cost screening modalities and low-dose aspirin can be deployed in developing countries to curb pre-eclampsia.

Indexed as

burdenmanagementnational policiespre-eclampsiaprevention

Identifiers

PMID37444666
PMCPMC10341070
OpenAlexW4382136634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.